House, Senate Take Aim at Drug Prices

Drug Industry Daily
The House and Senate will each take a hard look at drug prices Tuesday, one in a mark-up that would require drugmakers to make public justifications for price increases or high launch prices, the other in a hearing that will gather executives from some of the nation’s largest pharmacy benefit managers.

To View This Article:


Subscribe To Drug Industry Daily